Back in January this year, we summarised the key trends our market access experts believed would dom...
Read moreWe're thrilled to announce our participation at ISPOR Europe 2023 in Copenhagen this November. We'll...
Read moreWe summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H...
Read moreWebinar: Our experts discuss NICE's proportionate approach to technology appraisals and the implicat...
Read moreThis research aims to understand if just three PICOs are feasible by analysing recent HTA assessment...
Read moreOur research aims to gauge awareness of the new EU HTA process within the pharmaceutical industry in...
Read moreGermany is reshaping its Ministry of Health to prioritize the prevention of diseases like cancer, de...
Read moreIn a ground breaking move, the international collaboration among six prominent health technology ass...
Read moreOur market access experts provide an overview of how to get payer scientific advice between Septembe...
Read moreSpain's National Court recently invalidated the proposed plan for consolidating therapeutic position...
Read more